Oral Azacitidine for the Treatment of Relapsed or Refractory T-cell Large Granular Lymphocytic Leukemia

NCT05141682 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

11

Enrollment

OTHER

Sponsor class

Conditions

T-Cell Large Granular Lymphocyte Leukemia

Interventions

DRUG: Oral Azacitidine

Sponsor

Jonathan Brammer

Collaborators

[object Object]